How Does Salamol Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Salamol Works
- Active Ingredient: Salbutamol sulphate (100 micrograms per actuation).
- Primary Action: Selective beta2‑adrenoceptor agonist that relaxes bronchial smooth muscle within minutes.
- Onset & Duration: Relief starts in 3–5 minutes; effects last 4–6 hours.
- Metabolism: Hepatic sulfation to inactive metabolite; excreted mainly in urine.
- Usage: Short‑acting reliever for acute asthma symptoms, not for maintenance.
Salamol (salbutamol) is a fast‑acting reliever inhaler that works by activating beta2‑receptors in the airways, causing rapid muscle relaxation and improved airflow. This page explains the detailed pharmacology behind its action.
Important Medical Advice
Stop using Salamol and seek immediate medical help if your breathing worsens or you wheeze after using the inhaler, or if you develop signs of allergic reaction (swelling of face/lips, rash). If you have heart disease and experience chest pain or worsening symptoms, seek urgent care.
Chemical Composition & Molecular Structure
Salamol CFC‑Free Inhaler contains salbutamol sulphate as the active ingredient. Each metered dose delivers 100 micrograms of salbutamol base. The excipients are anhydrous ethanol and the propellant norflurane (HFA‑134a), a hydrofluoroalkane that replaces ozone‑damaging CFCs.
Structural Details
α¹‑[(tert‑Butylamino)methyl]‑4‑hydroxy‑m‑xylene‑α¹,α³‑diol sulphate (2:1)
A synthetic phenylethanolamine with a selective beta2‑adrenoceptor agonist profile. The sulphate salt improves stability and solubility.
1,1,1,2‑tetrafluoroethane
An inert, non‑ozone depleting propellant that generates the aerosol for lung delivery. It quickly evaporates upon actuation.
Key Pharmaceutical Properties
| Property | Salbutamol |
|---|---|
| Lipophilicity (logP) | 0.64 |
| Protein binding | 8–10% |
| pKa | 9.3 (amine), 10.3 (phenolic) |
| Oral bioavailability | ~50% (but extensive first‑pass) |
| Receptor selectivity | Beta2 : Beta1 ≈ 30:1 |
🗒️ Pharmaceutical insight: The absence of CFCs makes Salamol environmentally friendly while maintaining efficient lung deposition.
Mechanism of Action: Beta2‑Adrenergic Pathway
Salbutamol is a short‑acting beta2‑agonist (SABA) that produces bronchodilation through a well‑defined cellular pathway.
- Receptor binding: After inhalation, salbutamol binds to beta2‑adrenoceptors on airway smooth muscle cells. These receptors are G‑protein coupled.
- Adenylate cyclase activation: The receptor–Gs protein complex stimulates adenylate cyclase, converting ATP to cyclic AMP (cAMP).
- Protein kinase A (PKA) activation: Elevated cAMP activates PKA, which phosphorylates multiple targets, including myosin light chain kinase, leading to smooth muscle relaxation.
- Additional effects: Salbutamol also inhibits mast cell mediator release and enhances mucociliary clearance.
| Feature | Salbutamol |
|---|---|
| Onset of action | 3–5 minutes |
| Peak effect | 30–60 minutes |
| Duration | 4–6 hours |
🗒️ Physiological insight: The rapid onset makes salbutamol ideal for relieving acute bronchospasm, but its short duration means it should not be used as a long‑term controller.
Absorption & Distribution (Pharmacokinetics)
Following inhalation, approximately 10–20% of the emitted dose reaches the lower airways; the remainder is deposited in the oropharynx and swallowed.
Pulmonary absorption
Salbutamol is rapidly absorbed from the lung surface into the systemic circulation. Peak plasma concentrations occur within 5–10 minutes after inhalation.
Distribution
Salbutamol has a volume of distribution of about 2 L/kg. It crosses the placenta and appears in breast milk in negligible amounts. Plasma protein binding is low (8–10%).
Metabolic Effects & Elimination
Hepatic metabolism: Salbutamol is metabolised predominantly by sulfotransferase enzymes (SULT1A3) to an inactive metabolite, salbutamol 4'‑O‑sulfate. A minor pathway involves glucuronidation.
Excretion: About 64% of a dose is excreted in urine (30% as unchanged drug, the remainder as the sulfate conjugate). Faecal excretion accounts for approximately 13%. The elimination half‑life ranges from 2.7 to 5 hours.
⚠️ Metabolic caution: In severe hepatic impairment, metabolism may be reduced, leading to higher systemic exposure. Dose adjustment is not usually required but monitoring advised.
Clinical Efficacy in Asthma Management
Salamol is indicated for symptomatic relief of asthma and other conditions with reversible airways obstruction. It improves FEV₁ by 15–20% within 5–10 minutes, with maximal effect at one hour. It is also used to prevent exercise‑induced bronchoconstriction when taken 15–30 minutes before exercise.
In regular use, salbutamol reduces airway resistance and decreases the need for rescue interventions. However, increasing use signals poor asthma control and requires step‑up of anti‑inflammatory therapy (e.g., inhaled corticosteroids).
Salamol FAQs
How long does it take for Salamol to work?
Salamol starts working within 3–5 minutes, providing rapid relief of breathlessness and wheeze. Peak effect occurs around 30–60 minutes after inhalation.
Can I use Salamol too often?
Yes. Using it more than twice a week for symptom relief suggests poorly controlled asthma; you should see your doctor to adjust your maintenance therapy.
What are the common side effects of Salamol?
Common side effects include fine tremor (usually hands), headache, and tachycardia. These are usually mild and transient.
Is Salamol safe during pregnancy?
Salbutamol is generally considered safe when used as needed. Uncontrolled asthma poses greater risks to mother and baby; consult your doctor for individual advice.
Can I clean my Salamol inhaler?
Yes. Remove the metal canister (do not put it in water), rinse the plastic mouthpiece and cap under warm water for 30 seconds, shake off excess, and dry thoroughly before reassembling.
Need Salamol with Expert Guidance?
If you rely on a reliever inhaler like Salamol, a structured review with a UK‑registered doctor ensures your asthma plan is optimised.
Secure Prescription & Next-Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Asthma ConsultationRelated Salamol Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 8 March 2026
Next Review: 8 September 2026
Published on: 8 March 2026
Last Updated: 8 March 2026